Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Notes Payables (2021 - 2024)

Historic Notes Payables for IM Cannabis (IMCC) over the last 4 years, with Q4 2024 value amounting to $10.8 million.

  • IM Cannabis' Notes Payables rose 2178.99% to $10.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.8 million, marking a year-over-year increase of 2178.99%. This contributed to the annual value of $11.1 million for FY2024, which is 2315.36% up from last year.
  • Per IM Cannabis' latest filing, its Notes Payables stood at $10.8 million for Q4 2024, which was up 2178.99% from $8.9 million recorded in Q4 2023.
  • Over the past 5 years, IM Cannabis' Notes Payables peaked at $10.8 million during Q4 2024, and registered a low of $6.8 million during Q4 2022.
  • Its 4-year average for Notes Payables is $8.4 million, with a median of $7.9 million in 2021.
  • Its Notes Payables has fluctuated over the past 5 years, first plummeted by 112.89% in 2022, then skyrocketed by 3068.73% in 2023.
  • Over the past 4 years, IM Cannabis' Notes Payables (Quarter) stood at $6.9 million in 2021, then fell by 1.13% to $6.8 million in 2022, then surged by 30.69% to $8.9 million in 2023, then increased by 21.79% to $10.8 million in 2024.
  • Its Notes Payables was $10.8 million in Q4 2024, compared to $8.9 million in Q4 2023 and $6.8 million in Q4 2022.